Delivery Order SPE2DB20D3101-SPE2DB22FJ3C4
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,207.29, is for the delivery of Sirolimus 1 mg tablets. The award falls under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (the parent company of Amerisourcebergen Drug Corp) and the DLA, valued at up to $999,999,999.00 and running through December 2025. This IDC serves...
- This is a $4,196.80 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. AmerisourceBergen was awarded the delivery order to provide Sirolimus 1 mg/ml solution, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen, valued up to $999,999,999.00...
- This federal contract award, with a ceiling value of $1,384.75, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Sirolimus 1 mg tablets and is a Firm Fixed Price Delivery Order, with an ultimate completion date of December 28, 2023. The contract is not designated as a set-aside award, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award is for the delivery of Sirolimus 1 mg tablets in quantities of 100 to the Defense Logistics Agency (DLA). The contract, valued at $3,012.92, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a firm fixed-price delivery order with a completion date of January 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Sirolimus 1 mg tablets. The contract, valued at $4,949.51, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 tablets of the pharmaceutical product SIROLIMUS 2 MG. The $2,080.06 order has a completion date of December 22, 2023 and was placed without the use of a set-aside. Amerisourcebergen Drug Corp, through its Corporate Office division, has extensive experience as a prime contractor supplying pharmaceuticals, medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Sirolimus 1 mg/ml Solution in 60ml quantities, with a ceiling value of $6,938.53 and a firm fixed price structure. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $1,100.00. The contract is for the delivery of Sirolimus 1 mg tablets, a medication commonly used to prevent organ rejection in transplant patients. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor for this...
- This federal contract award to Amerisourcebergen Drug Corp is for the delivery of TACROLIMUS 5 MG CAPSULE (IR) 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award has a ceiling value of $4,838.82 and is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of up to $999,999,999 through December 2025. The contract is a firm-fixed-price agreement and does not have a set-aside designation....
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,162.03 firm fixed-price delivery order is for the provision of various pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials such as syringes and vials. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FJ3C4Delivery Order
This federal contract award is a delivery order (SPE2DB22FJ3C4) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,657.99 firm fixed-price contract is for the supply of SIROLIMUS 1 MG/ML SOLUTION 60ML, a specialty pharmaceutical product. The award, which has no set-aside designation, supports the DLA's Troop Support Medical program by providing essential medical supplies to military treatment facilities, veteran healthcare programs, and other federal medical institutions. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical and medical products to the Department of Defense worldwide. This IDC, along with a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, demonstrates Amerisourcebergen's critical role in meeting the diverse healthcare needs of the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 3/30/22 |